Allozymes Welcomes Dr. Andreas Reindl as Chief Operating Officer to Accelerate Strategic Growth
July 14, 2025
Allozymes welcomes Dr. Andreas Reindl as Chief Operating Officer to lead strategic operations and global scale-up. With deep biotech and industry experience, Andreas will drive execution across teams and strengthen our ability to deliver enzyme solutions reliably and at scale.